Compare ADCT & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADCT | POWW |
|---|---|---|
| Founded | 2011 | 1990 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 496.7M | 209.6M |
| IPO Year | 2020 | N/A |
| Metric | ADCT | POWW |
|---|---|---|
| Price | $4.28 | $1.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $7.60 | $2.38 |
| AVG Volume (30 Days) | ★ 1.6M | 357.1K |
| Earning Date | 11-10-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $75,209,000.00 | $46,632,638.00 |
| Revenue This Year | $10.36 | $9.85 |
| Revenue Next Year | $3.87 | $1.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.35 | ★ 1343.57 |
| 52 Week Low | $1.05 | $0.95 |
| 52 Week High | $4.80 | $2.14 |
| Indicator | ADCT | POWW |
|---|---|---|
| Relative Strength Index (RSI) | 55.06 | 62.68 |
| Support Level | $3.15 | $1.97 |
| Resistance Level | $4.62 | $1.96 |
| Average True Range (ATR) | 0.40 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 77.98 | 75.64 |
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.